| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |